Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study

PURPOSE: Extensively drug-resistant Acinetobacter baumannii (XDRAB) is an important cause of nosocomial pneumonia with limited therapeutic options. Colistin-based regimen is the recommended treatment. Which drugs should be combined with colistin remains uncertain. The aim of this study was to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungthammakhun, Chutchawan, Vasikasin, Vasin, Changpradub, Dhitiwat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750850/
https://www.ncbi.nlm.nih.gov/pubmed/31571943
http://dx.doi.org/10.2147/IDR.S225518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750850/
https://www.ncbi.nlm.nih.gov/pubmed/31571943
http://dx.doi.org/10.2147/IDR.S225518

Ejemplares similares